» Articles » PMID: 21775515

Impaired Humoral Response to Vaccines Among HIV-exposed Uninfected Infants

Abstract

Little is known about the vaccine protective response for infants born from HIV-infected mothers. We evaluated the antibody response to hepatitis B, tetanus, and diphtheria vaccine in vertically HIV-exposed uninfected infants and compared them to those of control infants not exposed to the virus. The quantitative determination of specific neutralizing antibodies against hepatitis B, diphtheria, and tetanus were performed blindly on serum samples. The results showed that 6.7% of the HIV-exposed uninfected individuals were nonresponders to hepatitis B vaccine (anti-HBs titer, <10 mIU/ml), and 64.4% were very good responders (anti-HBs titer, ≥1,000 mIU/ml), whereas only 3.6% of the nonexposed infants were nonresponders (χ(2)=10.93; 1 df). The HIV-exposed uninfected infants showed protective titers for diphtheria and tetanus but lower geometric mean anti-tetanus titers compared to those of the HIV-unexposed infants. Our data point to the necessity of evaluating vaccine immune responses in these children and reinforced that alterations in lymphocyte numbers and functions reported for newborns from HIV-infected mothers interfere with the vaccine response.

Citing Articles

Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children.

Kelly M, Cunningham C, McFarland E, Giganti M, Lindsey J, Perlowski C Open Forum Infect Dis. 2024; 11(12):ofae679.

PMID: 39610407 PMC: 11604081. DOI: 10.1093/ofid/ofae679.


HIV-exposed uninfected infants' immune defects: From pathogen sensing, oxidative burst to antigens responses.

Djoba Siawaya J, Maloupazoa Siawaya A iScience. 2023; 26(12):108427.

PMID: 38077134 PMC: 10708997. DOI: 10.1016/j.isci.2023.108427.


Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications.

Mataramvura H, Bunders M, Duri K Front Immunol. 2023; 14:1182217.

PMID: 37350953 PMC: 10282157. DOI: 10.3389/fimmu.2023.1182217.


Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.

Uffman E, Li S, Chen J, Allen N, Boiditswe S, Fouda G Vaccine. 2022; 40(33):4764-4771.

PMID: 35773120 PMC: 9912097. DOI: 10.1016/j.vaccine.2022.06.059.


Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy.

Afran L, Jambo K, Nedi W, Miles D, Kiran A, Banda D J Infect Dis. 2022; 226(7):1243-1255.

PMID: 35403683 PMC: 9518837. DOI: 10.1093/infdis/jiac133.


References
1.
Siriaksorn S, Puthanakit T, Sirisanthana T, Sirisanthana V . Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine. 2006; 24(16):3095-9. DOI: 10.1016/j.vaccine.2006.01.045. View

2.
Sonobe M, Trezena A, Guilhen F, Takano V, Fratelli F, Sakauchi D . Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test. Braz J Med Biol Res. 2007; 40(1):69-76. DOI: 10.1590/s0100-879x2007000100009. View

3.
Scott S, Moss W, Cousens S, Beeler J, Audet S, Mugala N . The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis. 2007; 45(11):1417-24. DOI: 10.1086/522989. View

4.
Carniel E, Morcillo A, Blotta M, da Silva M, Mazzola T, Antonio M . Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. Vaccine. 2007; 26(5):647-52. DOI: 10.1016/j.vaccine.2007.11.048. View

5.
Moss W, Clements C, Halsey N . Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ. 2003; 81(1):61-70. PMC: 2572316. View